Clinical practice and implication of intensive lipid-lowering therapy / 基础医学与临床

ABSTRACT

Cardiovascular high risk population should receive intensive lipid-lowering therapy to reduce low density lipoprotein-cholesterol(LDL-C) below(2.6 mmol/L) or(1.8 mmol/L).This therapy can stop or regress atherosclerotic lesion,prevent and treat acute coronary syndrome.Individuals of coronary heart disease or risk equivalents can be benefited from intensive lipid-lowering therapy.